MAXIMUM DIFFERENCE SCALING- A NOVEL TECHNIQUE FOR DETERMINING PATIENT PREFERENCES

Author(s)

Stephenson JJ1, Kern DM2, Wu B2, Tunceli O2, Rodriguez A2, Horne LN3, Sackeyfio A4, Mackillop N4
1HealthCore Inc, Wilmington, DE, USA, 2HealthCore, Inc., Wilmington, DE, USA, 3AstraZeneca Pharmaceuticals LP, Wilmington, DE, USA, 4AstraZeneca, Alderley Park, UK

OBJECTIVES: Maximum Difference Scaling (MaxDiff) is a survey research technique for obtaining preference scores for a set of items that provides greater discrimination between items while indicating how strongly an item is preferred. This study investigated the use of MaxDiff as a means of determining patient-reported importance of medication treatment attributes. METHODS: MaxDiff was used in a survey of rheumatoid arthritis (RA) patients to determine the importance and relative rank of specific attributes of RA treatments. The following attributes were selected based upon literature review and opinions of the research team: 1) Reduces pain; 2) Potential side effects; 3) How often treatment taken; 4) How treatment is given; 5) Where treatment is given; 6) Personal costs; 7) Works quickly; 8) How long treatment effects last; 9) Keeps disease from getting worse; and 10) Improves physical abilities. Respondents were shown 10 sets of 4 attributes and, for each set, were asked to indicate the RA treatment attribute that was most important and least important to them. The attribute sets were selected using an experimental design that showed each attribute an equal number of times and in different order within the sets. Hierarchical Bayesian techniques were used to derive respondent-level attribute importance scores and, based on the importance scores a relative rank order was developed for each attribute.   RESULTS: Based on 291 surveys, MaxDiff attribute importance scores ranged from 13 to 209 with higher scores indicating increased importance. Preventing the disease from getting worse, improving physical abilities, and reduction in pain were the most important RA treatment attributes, all having scores >195, while the ‘how’, ‘when’, and ‘where’ treatment administration attributes were the least important, all having scores ­<15. CONCLUSIONS: MaxDiff importance scores demonstrated discrimination among attributes and respondents and should be considered as an alternative to more traditional ranking and rating approaches.

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PP2

Topic

Methodological & Statistical Research

Topic Subcategory

PRO & Related Methods

Disease

Musculoskeletal Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×